Literature DB >> 23414429

Impact of preterm birth and bronchopulmonary dysplasia on the developing lung: long-term consequences for respiratory health.

Megan O'Reilly1, Foula Sozo, Richard Harding.   

Abstract

Preterm birth affects 8-10% of human pregnancies and is a major cause of long-term disability. Individuals who are born very preterm, especially if they develop bronchopulmonary dysplasia (BPD), have an increased risk of impaired lung function in infancy, childhood and adulthood, as well as an increased risk of respiratory illness. Our aim is to briefly review current understanding of the basis for long-term impairments in lung function and respiratory health following preterm birth and BPD. Histopathology of the lungs of infants and children following preterm birth and BPD shows altered development of the lung parenchyma, conducting airways and pulmonary vasculature. Owing to improvements in the care of preterm infants, especially the use of exogenous surfactant and lower concentrations of administered oxygen, lung pathology following preterm birth and BPD is less severe than in the past. Recent studies indicate that very preterm birth and BPD can lead to hyperplasia of airway smooth muscle, impaired alveolarization, pulmonary inflammation and an increase in pulmonary artery muscularization. Imaging of adult lungs suggests that the deficit in alveoli can persist into later life. Long-term lung injury apparently relates to the use of mechanical ventilation and the use of supplemental oxygen in infancy. Impaired lung function in later life is due to airway hyper-reactivity and fewer alveoli, resulting in reductions in the surface area for gas exchange and physical support for bronchioles. Because the incidence of preterm birth is not declining, it will continue to be a major cause of respiratory ill-health in adults.
© 2013 The Authors Clinical and Experimental Pharmacology and Physiology © 2013 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  developmental programming; lung development; lung injury; prematurity; pulmonary hypertension

Mesh:

Substances:

Year:  2013        PMID: 23414429     DOI: 10.1111/1440-1681.12068

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  33 in total

1.  Neonatal hyperoxia promotes asthma-like features through IL-33-dependent ILC2 responses.

Authors:  In Su Cheon; Young Min Son; Li Jiang; Nicholas P Goplen; Mark H Kaplan; Andrew H Limper; Hirohito Kita; Sophie Paczesny; Y S Prakash; Robert Tepper; Shawn K Ahlfeld; Jie Sun
Journal:  J Allergy Clin Immunol       Date:  2017-12-15       Impact factor: 10.793

2.  Moderate preterm birth affects right ventricular structure and function and pulmonary artery blood flow in adult sheep.

Authors:  Marshall M Mrocki; Vivian B Nguyen; Paul Lombardo; Megan R Sutherland; Jonathan G Bensley; Ilias Nitsos; Beth J Allison; Richard Harding; Robert De Matteo; Michal Schneider; Graeme R Polglase; M Jane Black
Journal:  J Physiol       Date:  2018-04-06       Impact factor: 5.182

3.  Prediction of prolonged ventilator dependence in preterm infants.

Authors:  Kamal Ali; Sabena Kagalwalla; Iram Cockar; Emma E Williams; Kentaro Tamura; Theodore Dassios; Anne Greenough
Journal:  Eur J Pediatr       Date:  2019-05-11       Impact factor: 3.183

4.  Airway metabolome and chronic lung disease of prematurity.

Authors:  Deepa Rastogi; Judy L Aschner
Journal:  J Pediatr       Date:  2014-10-23       Impact factor: 4.406

5.  Therapeutic effects of fibroblast growth factor-10 on hyperoxia-induced bronchopulmonary dysplasia in neonatal mice.

Authors:  Tao Han; Ming Chi; Yan Wang; Yabo Mei; Qiuping Li; Mengnan Yu; Qianqian Ma; Yuhan Chen; Zhichun Feng
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

6.  Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia.

Authors:  Thilo J Witsch; Pawel Turowski; Elpidoforos Sakkas; Gero Niess; Simone Becker; Susanne Herold; Konstantin Mayer; István Vadász; Jesse D Roberts; Werner Seeger; Rory E Morty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-27       Impact factor: 5.464

7.  Bronchopulmonary Dysplasia: Executive Summary of a Workshop.

Authors:  Rosemary D Higgins; Alan H Jobe; Marion Koso-Thomas; Eduardo Bancalari; Rose M Viscardi; Tina V Hartert; Rita M Ryan; Suhas G Kallapur; Robin H Steinhorn; Girija G Konduri; Stephanie D Davis; Bernard Thebaud; Ronald I Clyman; Joseph M Collaco; Camilia R Martin; Jason C Woods; Neil N Finer; Tonse N K Raju
Journal:  J Pediatr       Date:  2018-03-16       Impact factor: 4.406

8.  Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia.

Authors:  Alison W Ha; Tara Sudhadevi; David L Ebenezer; Panfeng Fu; Evgeny V Berdyshev; Steven J Ackerman; Viswanathan Natarajan; Anantha Harijith
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-07-22       Impact factor: 5.464

Review 9.  The physiological determinants of sudden infant death syndrome.

Authors:  Alfredo J Garcia; Jenna E Koschnitzky; Jan-Marino Ramirez
Journal:  Respir Physiol Neurobiol       Date:  2013-06-02       Impact factor: 1.931

Review 10.  Should we still use vitamin A to prevent bronchopulmonary dysplasia?

Authors:  X I Couroucli; J L Placencia; L A Cates; G K Suresh
Journal:  J Perinatol       Date:  2016-05-26       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.